Literature DB >> 17852127

Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD).

Andrew M Snyder1, Paul Maruff, Robert H Pietrzak, Jennifer R Cromer, Peter J Snyder.   

Abstract

This study used a novel hidden maze learning test to examine the nature and magnitude of impairment on separable aspects of executive function in 36 children with ADHD. A within-subject analysis of children with ADHD was also conducted to assess cognitive effects of open-label stimulant treatment. Compared to 31 age-matched controls, unmedicated children with ADHD were slower and made significantly more errors that were indicative of relative impairment in prepotent response inhibition and ability to "maintain set" while using simple rules to complete the task. Open-label administration of stimulant medication led to faster and more efficient performance, with children with ADHD making fewer perseverative and rule-break errors than when off medication. This instrument might be useful in monitoring treatment response in specific aspects of executive function and in assisting with dose-titration decisions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852127     DOI: 10.1080/09297040701220005

Source DB:  PubMed          Journal:  Child Neuropsychol        ISSN: 0929-7049            Impact factor:   2.500


  11 in total

Review 1.  CNTRICS final task selection: executive control.

Authors:  Deanna M Barch; Todd S Braver; Cameron S Carter; Russell A Poldrack; Trevor W Robbins
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

Review 2.  Behavior at the choice point: decision making in hidden pathway maze learning.

Authors:  Elizabeth Thomas; Peter J Snyder; Robert H Pietrzak; Paul Maruff
Journal:  Neuropsychol Rev       Date:  2014-10-28       Impact factor: 7.444

3.  Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131.

Authors:  Wanda L Salzer; Michael J Burke; Meenakshi Devidas; Yunfeng Dai; Kristina K Hardy; John A Kairalla; Lia Gore; Joanne M Hilden; Eric Larsen; Karen R Rabin; Patrick A Zweidler-McKay; Michael J Borowitz; Brent Wood; Nyla A Heerema; Andrew J Carroll; Naomi Winick; William L Carroll; Elizabeth A Raetz; Mignon L Loh; Stephen P Hunger
Journal:  J Clin Oncol       Date:  2020-06-04       Impact factor: 44.544

4.  The effect of methylphenidate and rearing environment on behavioral inhibition in adult male rats.

Authors:  Jade C Hill; Pablo Covarrubias; Joel Terry; Federico Sanabria
Journal:  Psychopharmacology (Berl)       Date:  2011-11-05       Impact factor: 4.530

5.  A review of executive function deficits and pharmacological management in children and adolescents.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-08

6.  Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.

Authors:  Stephen A Sands; Brian T Harel; Mirko Savone; Kara Kelly; Veena Vijayanathan; Jennifer Greene Welch; Lynda Vrooman; Lewis B Silverman; Peter D Cole
Journal:  Support Care Cancer       Date:  2016-10-10       Impact factor: 3.603

7.  Computerized assessment of cognitive impairment among children undergoing radiation therapy for medulloblastoma.

Authors:  Andrew M Heitzer; Jason M Ashford; Brian T Harel; Adrian Schembri; Michelle A Swain; Joanna Wallace; Kirsten K Ness; Fang Wang; Hui Zhang; Thomas E Merchant; Giles W Robinson; Amar Gajjar; Heather M Conklin
Journal:  J Neurooncol       Date:  2018-11-22       Impact factor: 4.130

8.  Detecting subtle changes in visuospatial executive function and learning in the amnestic variant of mild cognitive impairment.

Authors:  Kathryn V Papp; Peter J Snyder; Paul Maruff; Jennifer Bartkowiak; Robert H Pietrzak
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

9.  Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD.

Authors:  Barbara D'Aiello; Silvia Di Vara; Pietro De Rossi; Italo Pretelli; Stefano Vicari; Deny Menghini
Journal:  Int J Environ Res Public Health       Date:  2022-01-31       Impact factor: 3.390

Review 10.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.